GSK’s (GSK) Buy Rating Reaffirmed at Shore Capital
Shore Capital reaffirmed their buy rating on shares of GSK (LON:GSK – Get Rating) in a report released on Monday morning, MarketBeat.com reports. Other equities analysts have also recently issued research reports about the company. Jefferies Financial Group set a GBX 1,575 ($19.73) price target on GSK in a report on Wednesday, February 1st. Berenberg … [Read more…]